Revision sheet: Immunology: Autoimmunity and Hypersensitivity

📋 Course Outline

1. Immune System Functions
2. Hypersensitivity Types
3. Autoimmune Disorders
4. Immunodeficiency Causes
5. HIV Pathogenesis
6. Chemotherapy Effects
7. Autoimmune Disease Treatment
8. Immunosuppressive Drugs
9. Neutropenia and Infection
10. Specific Pathologies

📖 1. Immune System Functions

🔑 Key Concepts & Definitions

• Antigen: A substance that triggers an immune response, typically a foreign protein, polysaccharide, or molecule recognized by the immune system (source content).
• Antibodies: Proteins produced by B cells that specifically recognize and bind to antigens, facilitating their neutralization or destruction (source content).
• B cells: A type of lymphocyte responsible for producing antibodies, playing a crucial role in humoral immunity (source content).
• Macrophages: Phagocytic immune cells that engulf pathogens, present antigens to T cells, and secrete cytokines to coordinate immune responses (source content).
• Cytotoxic T cells (CD8): T lymphocytes that directly kill infected or cancerous cells by recognizing specific antigens presented on their surface (source content).
• Helper T cells (CD4): T lymphocytes that assist other immune cells by releasing cytokines, enhancing the immune response, and aiding B cell activation (source content).
• Dendritic cells: Antigen-presenting cells that process antigens and present them to T cells, initiating adaptive immunity (source content).
• Complement system: A group of plasma proteins that enhance immune responses through pathogen opsonization, cell lysis, and inflammation (source content).
• Mast cells: Cells involved in allergic reactions that release histamine and other mediators upon activation, contributing to inflammation (source content).
• Tolerance: The immune system's ability to distinguish self from non-self, preventing attacks on self-proteins and innocuous substances (source content).
• Immune system balance: The finely tuned regulation of immune responses to effectively eliminate threats while avoiding damage to self, with its loss leading to pathologies such as hypersensitivity or autoimmunity (source content).

📝 Essential Points

• The immune system's primary role is to defend against external threats like pathogens and internal threats such as cancer cells, while maintaining tolerance to self-proteins and harmless substances (source content).
• Key immune cells include B cells (antibody producers), macrophages (phagocytes and antigen presenters), cytotoxic T cells (kill infected/cancer cells), helper T cells (coordinate immune responses), dendritic cells (antigen presentation), neutrophils (rapid responders to infection), and mast cells (mediate allergic reactions) (source content).
• The complement system functions as an amplification cascade that enhances pathogen clearance through opsonization, cell lysis, and recruitment of immune cells (source content).
• The immune response is initiated when antigens are recognized by specific antibodies or immune cells, leading to targeted destruction or neutralization (source content).
• Maintaining immune system balance is critical; disruption can lead to hypersensitivity reactions or autoimmune diseases, where the immune system attacks self or harmless substances (source content).

💡 Key Takeaway

The immune system is a complex network of cells and proteins that protects the organism from threats while maintaining tolerance to self, with its proper regulation essential to prevent immune-related pathologies.

📖 2. Hypersensitivity Types

🔑 Key Concepts & Definitions

• Hypersensitivity reactions (Dr. Sara Vernocchi): Inappropriate activation of the immune system against harmless environmental antigens or self-antigens, leading to tissue damage or systemic disease.

• Type I hypersensitivity (Dr. Sara Vernocchi, 2024): IgE-mediated immediate allergic reactions characterized by rapid response within minutes, involving mast cell activation and histamine release, causing conditions like urticaria, asthma, and anaphylaxis.

• Type II hypersensitivity (Dr. Sara Vernocchi, 2024): Cytotoxic reactions mediated by IgG antibodies targeting cell surface or extracellular matrix components, leading to cell destruction via natural killer cells or complement activation, seen in diseases like myasthenia gravis and hemolytic anemia.

• Type III hypersensitivity (Dr. Sara Vernocchi, 2024): Immune complex-mediated systemic vasculitis caused by deposition of IgG immune complexes in blood vessels, activating complement and inflammation, as observed in systemic lupus erythematosus.

• Type IV hypersensitivity (Dr. Sara Vernocchi, 2024): T cell-mediated delayed hypersensitivity involving helper and cytotoxic T cells, leading to tissue inflammation and damage, exemplified by contact dermatitis and multiple sclerosis.

📝 Essential Points

• Hypersensitivity reactions are classified into four types based on the immune components involved and the timing of the response. Type I is immediate and IgE-dependent, primarily involving mast cells and histamine release, leading to allergic symptoms. Type II involves IgG antibodies causing targeted cell destruction, often in autoimmune conditions. Type III results from immune complex deposition, causing systemic vasculitis and tissue damage, notably in systemic lupus erythematosus. Type IV is T cell-mediated, with delayed onset, causing chronic inflammation as seen in multiple sclerosis and contact dermatitis.

• Examples of hypersensitivity diseases include allergies (Type I), Guillain-Barré syndrome (Type II, immune response against nerve components), myasthenia gravis (Type II, autoantibodies against neuromuscular junction), systemic lupus erythematosus (Type III), rheumatoid arthritis (immune complex deposition in joints), and multiple sclerosis (Type IV, T cell attack on CNS myelin).

• The immune response in hypersensitivity reactions can be triggered by infections (molecular mimicry), environmental allergens, or self-antigens, leading to tissue-specific or systemic pathology.

💡 Key Takeaway

Hypersensitivity reactions are immune system overreactions that cause tissue damage, classified into four types based on their immune mechanisms, with each type associated with specific diseases and clinical features.

📖 3. Autoimmune Disorders

🔑 Key Concepts & Definitions

• Loss of tolerance to self-antigens: A fundamental failure in the immune system where it begins to recognize and attack the body's own tissues, leading to autoimmune diseases (source content).
• Etiology of autoimmune diseases: The causes are multifactorial, involving genetic predisposition, hormonal influences, environmental factors, infections, diet, and toxic chemicals, often with an unknown precise trigger (source content).
• Treatment of autoimmune diseases: Primarily includes corticosteroids and NSAIDs to reduce inflammation and immune response, along with physical therapy when musculoskeletal involvement occurs (source content).
• Examples of autoimmune disorders: Systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and myasthenia gravis are key conditions characterized by immune-mediated tissue damage (source content).

📝 Essential Points

Autoimmune diseases result from a loss of immune tolerance to self-antigens, causing the immune system to attack the body's own tissues. The etiology is complex and often involves a combination of genetic, hormonal, and environmental factors, including infections, diet, and exposure to toxic chemicals, although the exact cause remains frequently unknown. Treatment strategies focus on suppressing inflammation and immune activity using corticosteroids and NSAIDs, with physical therapy playing a role in managing symptoms related to musculoskeletal involvement. Examples such as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and myasthenia gravis exemplify the diversity of autoimmune pathologies, affecting various organs and systems with distinct mechanisms of tissue destruction.

💡 Key Takeaway

Autoimmune diseases arise from a breakdown in immune tolerance to self-antigens, driven by multifactorial causes, and are managed mainly through immunosuppressive therapies and symptom-specific interventions.

📖 4. Immunodeficiency Causes

🔑 Key Concepts & Definitions

• Immunodeficiencies: Pathologies characterized by compromised immune function, where the immune system's ability to fight pathogens or cancer cells is diminished (source).
• Primary immunodeficiency: Congenital genetic mutations affecting the development or functioning of immune cells, leading to intrinsic immune system defects (source).
• Secondary immunodeficiency: Acquired conditions or factors that reduce immune response effectiveness in an otherwise normal immune system, such as infections, chemotherapy, or drugs (source).
• Consequences of immunodeficiency: Increased susceptibility to frequent, unusual, or opportunistic infections, and a higher prevalence of cancers due to impaired immune surveillance (source).

📝 Essential Points

• Immunodeficiencies can be primary (congenital) or secondary (acquired). Primary immunodeficiencies result from genetic mutations affecting immune cells, leading to intrinsic immune system defects (source).
• Secondary immunodeficiencies are caused by external factors such as infections (e.g., HIV), chemotherapy, immunosuppressive drugs, or environmental influences, which impair immune function despite a genetically normal immune system (source).
• Factors like drug-induced suppression (e.g., corticosteroids), chemotherapy, and HIV infection are common causes of secondary immunodeficiency, often leading to increased risk of infections and malignancies (source).
• Management focuses on treating the primary cause when possible, minimizing infection risks, and sometimes using prophylactic antibiotics or immunoglobulin replacement therapy (source).

💡 Key Takeaway

Immunodeficiencies arise either from genetic mutations impairing immune cell function (primary) or from external acquired factors (secondary), both resulting in increased vulnerability to infections and cancers.

📖 5. HIV Pathogenesis

🔑 Key Concepts & Definitions

• ssRNA (single-stranded RNA): The genetic material of HIV, consisting of two copies of single-stranded RNA, which serve as templates for reverse transcription into DNA (source content).
• Capsid: The protein shell of HIV that encases the viral RNA and enzymes; it protects the genetic material and facilitates entry into host cells.
• Enzymes (reverse transcriptase, integrase): Critical viral enzymes; reverse transcriptase converts viral ssRNA into DNA, enabling integration into the host genome, while integrase inserts the viral DNA into the DNA of CD4 T cells (source content).
• Envelope glycoprotein gp120: A surface protein on HIV that mediates attachment to CD4 receptors on T helper cells, initiating infection (source content).
• HIV as a retrovirus: A virus that reverse transcribes its RNA genome into DNA and integrates it into the host cell's DNA, causing a lifelong infection in CD4 T cells (source content).
• Routes of HIV transmission: The primary pathways include unprotected sexual intercourse, sharing needles during injecting drug use, and other contact with infected bodily fluids (source content).
• Progressive secondary immunodeficiency: The gradual weakening of the immune system caused by HIV, leading to increased susceptibility to opportunistic infections and certain cancers as CD4 T cell counts decline (source content).

📝 Essential Points

HIV is a retrovirus characterized by two copies of ssRNA enclosed within a capsid, surrounded by an envelope containing glycoprotein gp120, which facilitates attachment to CD4 T cells. The virus encodes enzymes such as reverse transcriptase, which converts ssRNA into DNA, and integrase, which inserts this DNA into the host genome, establishing a lifelong infection. HIV primarily spreads through unprotected sex, sharing contaminated needles, and contact with infected fluids. As the infection progresses, it causes secondary immunodeficiency by depleting CD4 T cells, impairing immune responses and leading to AIDS. Effective management involves antiretroviral therapy that suppresses viral replication, improving prognosis and reducing transmission risk.

💡 Key Takeaway

HIV is a retrovirus with ssRNA and specialized enzymes that integrate its genome into CD4 T cells, causing a progressive immunodeficiency primarily transmitted through unprotected sex and injecting drug use.

📖 6. Chemotherapy Effects

🔑 Key Concepts & Definitions

• Chemotherapy as a cause of secondary immunodeficiency: Chemotherapy can induce secondary immunodeficiency by damaging or depleting immune cells, particularly those that divide rapidly, leading to a compromised immune response (Bonagura & Rosenthal, 2020).

• Effects of chemotherapy on immune system function: Chemotherapy affects immune system function primarily through the reduction of immune cell populations such as neutrophils, lymphocytes, and other white blood cells, impairing the body's ability to fight infections (Blayney & Schwartzberg, 2022).

• Increased risk of infections and complications during chemotherapy: Due to immune suppression, patients undergoing chemotherapy are at heightened risk for infections, including opportunistic infections and febrile neutropenia, which can be life-threatening and may delay or complicate cancer treatment (Bonagura & Rosenthal, 2020).

📖 7. Autoimmune Disease Treatment

🔑 Key Concepts & Definitions

• Treatment strategies for autoimmune diseases: Approaches aimed at reducing immune system activity and controlling inflammation, including pharmacological and physical therapies, to prevent tissue damage and improve patient quality of life (see source content).

• Use of corticosteroids and NSAIDs to reduce inflammation and immune reaction: Pharmacological agents that suppress immune responses and inflammation; corticosteroids decrease cytokine production and lymphocyte activity, while NSAIDs inhibit cyclooxygenase enzymes to reduce prostaglandin synthesis, alleviating pain and swelling (see source content).

• Role of physical therapy in autoimmune diseases affecting bones, joints, muscles: Non-pharmacological intervention focusing on maintaining joint mobility, muscle strength, and functional capacity, thereby reducing disability and managing symptoms in autoimmune conditions impacting musculoskeletal tissues (see source content).

📝 Essential Points

• Treatment of autoimmune diseases primarily involves corticosteroids and NSAIDs, which help suppress inflammation and immune responses, thereby preventing tissue destruction and alleviating symptoms (see source content). Corticosteroids are especially effective in reducing cytokine production and lymphocyte activity but carry risks such as osteoporosis, impaired wound healing, and immunosuppression (see source content).

• Physical therapy plays a crucial role in managing autoimmune diseases affecting bones, joints, and muscles by maintaining joint function, reducing stiffness, and improving muscle strength. It complements pharmacological treatment and helps minimize disability, especially in conditions like rheumatoid arthritis and systemic lupus erythematosus (see source content).

• The combination of medication and physical therapy aims to control disease activity, reduce pain, and enhance functional independence, thereby improving overall quality of life for patients with autoimmune disorders (see source content).

💡 Key Takeaway

Effective management of autoimmune diseases involves a combination of pharmacological suppression of inflammation with corticosteroids and NSAIDs, alongside physical therapy to preserve musculoskeletal function and reduce disability.

📖 8. Immunosuppressive Drugs

🔑 Key Concepts & Definitions

• Use of immunosuppressive drugs: Medications designed to reduce or inhibit immune system activity, often used in organ transplantation to prevent rejection or in autoimmune diseases to control immune-mediated damage (source content).

• Corticosteroids: A class of immunosuppressive drugs that decrease inflammation by reducing the production of pro-inflammatory cytokines and lymphocytes, commonly prescribed for autoimmune conditions and transplant rejection (source content).

• Adverse effects of corticosteroids:

  • Osteoporosis: Impairment of bone matrix mineralization leading to increased fracture risk.
  • Impaired wound healing: Delayed tissue repair due to suppressed inflammatory response.
  • Drug-induced diabetes: Most common metabolic side effect, caused by corticosteroid-induced insulin resistance.
  • Myopathy: Muscle weakness and atrophy resulting from muscle protein catabolism.
  • Immunosuppression: Increased susceptibility to infections due to decreased immune cell activity (source content).

📝 Essential Points

• Immunosuppressive drugs are crucial in managing conditions requiring immune activity reduction, such as organ transplants and autoimmune diseases (source content).
• Corticosteroids are among the most widely used immunosuppressants, with a market value of approximately 10 billion USD/year, due to their potent anti-inflammatory effects (source content).
• Long-term or high-dose corticosteroid therapy is associated with significant adverse effects, including osteoporosis, impaired wound healing, drug-induced diabetes, myopathy, and increased risk of infections (source content).
• The adverse effects are dose-dependent and more prevalent with chronic use, necessitating careful monitoring and management strategies in clinical practice (source content).

💡 Key Takeaway

Immunosuppressive drugs, especially corticosteroids, are vital for controlling immune-related diseases but carry significant risks that require vigilant management to minimize adverse effects.

📖 9. Neutropenia and Infection

🔑 Key Concepts & Definitions

• Neutrophils: A type of innate immune cell that plays a crucial role in defending the organism against bacterial and fungal infections. They are among the first responders to infection, rapidly migrating to sites of tissue damage or invasion (see source content).
• Neutrophils' role in hypersensitivity: In hypersensitivity reactions, neutrophils are recruited to the affected tissues where they degranulate, releasing inflammatory mediators that contribute to tissue damage and allergic symptoms (see source content).
• Hypersensitivity reactions (specifically Type I): Immune responses caused by inappropriate activation against harmless environmental antigens, mediated by IgE antibodies, leading to mast cell degranulation and recruitment of neutrophils among other immune cells (see source content).
• Neutropenia: A condition characterized by abnormally low levels of neutrophils in the blood, which impairs the body's ability to fight infections, increasing susceptibility to bacterial and fungal infections (see source content).
• Recruitment and degranulation of neutrophils in hypersensitivity: During hypersensitivity reactions, neutrophils are attracted to the site of allergen exposure, where they degranulate, releasing histamine, enzymes, and other inflammatory mediators that amplify the allergic response and tissue inflammation (see source content).

📝 Essential Points

• Neutrophils are vital in early immune defense, especially against bacterial and fungal infections (see source content).
• In hypersensitivity reactions, neutrophils are recruited to tissues where they degranulate, releasing mediators like histamine, which contribute to inflammation, swelling, and other allergic symptoms (see source content).
• Neutropenia significantly increases infection risk because of the deficiency in neutrophil-mediated pathogen clearance, often resulting from chemotherapy or other acquired causes (see source content).
• The recruitment and degranulation of neutrophils in hypersensitivity reactions are key processes that exacerbate tissue damage and clinical symptoms, such as in allergic rhinitis, asthma, and urticaria (see source content).
• Managing neutropenia involves reducing infection risk through prophylactic antibiotics, growth factors, and vaccination, while hypersensitivity reactions are treated with antihistamines, corticosteroids, and epinephrine (see source content).

💡 Key Takeaway

Neutrophils are essential immune defenders that, when recruited and degranulated during hypersensitivity reactions, contribute to inflammation and allergy symptoms; their deficiency (neutropenia) markedly increases susceptibility to infections.

📖 10. Specific Pathologies

🔑 Key Concepts & Definitions

• Guillain-Barré syndrome: An acute paralytic neuropathy characterized by immune-mediated damage to peripheral nerve myelin, often triggered by infections, with antibodies directed against myelin sheaths or axons of neurons (Shahrizaila et al., 2021).
• Myasthenia gravis: A chronic autoimmune disorder where antibodies target nicotinic acetylcholine receptors at the neuromuscular junction, leading to impaired nerve-muscle communication and muscle weakness (Muppidi, 2012).
• Systemic lupus erythematosus (SLE): A systemic autoimmune disease marked by the production of antibodies against nuclear and cytoplasmic proteins, causing widespread tissue inflammation and damage (Fortuna & Brennan, 2013).
• Rheumatoid arthritis: A chronic autoimmune condition involving immune complex deposition in synovial joints, resulting in systemic inflammation, joint destruction, and extra-articular manifestations (Scherer et al., 2020).
• Multiple sclerosis: A T cell-mediated demyelinating disease of the central nervous system where immune cells attack the myelin sheath, leading to neurological deficits and progressive disability (Tuano et al., 2021).

📝 Essential Points

• Guillain-Barré syndrome is often preceded by infections, with antibodies targeting myelin sheaths or axons, causing symmetrical ascending weakness, reduced reflexes, sensory disturbances, and cranial nerve deficits. Recovery occurs in approximately 80%, but 10-20% may experience long-term disability (Shahrizaila et al., 2021).
• Myasthenia gravis involves antibodies against ligand-gated sodium channels or nicotinic receptors at the neuromuscular junction, leading to fluctuating muscle weakness, especially in cranial muscles, with symptoms like double vision, drooping eyelids, and difficulty swallowing. A myasthenic crisis is a life-threatening emergency (Muppidi, 2012).
• Systemic lupus erythematosus manifests with relapsing-remitting symptoms affecting multiple organs, including fatigue, fever, weight changes, and systemic inflammation. Autoantibodies against nuclear and cytoplasmic proteins contribute to immune complex formation and tissue damage (Fortuna & Brennan, 2013).
• Rheumatoid arthritis is characterized by immune complex deposition in synovial joints, leading to symmetrical inflammation, cartilage and bone destruction, and potential extra-articular effects such as rheumatoid nodules and vasculitis. It involves both genetic and environmental factors (Scherer et al., 2020).
• Multiple sclerosis features progressive demyelination in the CNS driven by T cell attack on myelin, resulting in symptoms like fatigue, weakness, sensory loss, visual disturbances, and coordination problems. Subtypes include relapsing-remitting and progressive forms (Tuano et al., 2021).

💡 Key Takeaway

Pathologies such as Guillain-Barré syndrome, myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis are immune system disorders characterized by specific antibody or T cell-mediated attacks on neural or systemic tissues, leading to diverse neurological and systemic symptoms.

📅 Key Dates

(OMITTED: No significant dates provided in the content)

📊 Synthesis Tables

Aspect	Innate Immunity	Adaptive Immunity	Key Authors / Concepts
Cells involved	Macrophages, neutrophils, mast cells	B cells, T cells (CD4, CD8), dendritic cells	Louis Pasteur (antigen presentation), Paul Ehrlich (clonal selection)
Response time	Minutes to hours	Days to weeks	-
Main functions	Phagocytosis, inflammation, complement activation	Specific recognition, memory, antibody production	-
Key molecules	Complement proteins, cytokines	Antibodies, T cell receptors	-
Role in disease	First line defense, inflammation	Specific pathogen targeting, immune memory	-

Aspect	Hypersensitivity Type I	Hypersensitivity Type II	Hypersensitivity Type III	Hypersensitivity Type IV
Mechanism	IgE, mast cells	IgG, complement, NK cells	Immune complexes	T cells, delayed response
Timing	Immediate (minutes)	Minutes to hours	Hours to days	48-72 hours
Examples	Allergies, anaphylaxis	Hemolytic anemia, myasthenia gravis	Lupus, serum sickness	Contact dermatitis, MS
Key authors / concepts	Gell and Coombs classification	Gell and Coombs	Gell and Coombs	Gell and Coombs

Aspect	Autoimmune Disorders	Causes & Treatment
Main feature	Loss of self-tolerance	Multifactorial: genetic, environmental, hormonal
Examples	SLE, RA, MS, myasthenia gravis	Corticosteroids, NSAIDs, physical therapy
Pathogenesis	Autoantibody production, T cell attack	Unknown triggers, immune dysregulation
Authors / Concepts	Paul Ehrlich (self-tolerance), autoimmune etiology	-

⚠️ Common Pitfalls & Confusions

1. Confusing hypersensitivity types: Remember Type I is IgE-mediated, immediate; Type II involves cell destruction via IgG; Type III involves immune complexes; Type IV is T cell-mediated.
2. Mistaking autoimmune diseases for infectious diseases; autoimmune involves self-antigen attack, not pathogens.
3. Overlooking the role of complement in hypersensitivity types II and III.
4. Assuming all immune responses are protective; hypersensitivity and autoimmunity are pathological.
5. Confusing the cells involved in innate (macrophages, neutrophils) versus adaptive (B and T cells) immunity.
6. Misidentifying the timing of Type IV hypersensitivity as immediate—it's delayed (48-72 hours).
7. Ignoring the multifactorial causes of autoimmune diseases, including genetic and environmental factors.

✅ Exam Checklist

• Know the functions of key immune cells: B cells, T cells (CD4, CD8), macrophages, dendritic cells, mast cells, neutrophils.
• Understand the role of the complement system in immune responses.
• Define antigen and antibody, and their roles in immunity.
• Describe the four types of hypersensitivity reactions, including mechanisms and examples.
• Recognize the clinical diseases associated with each hypersensitivity type.
• Know the main causes and pathogenesis of autoimmune disorders.
• Understand the concept of immune tolerance and what leads to its loss.
• Recall key authors and concepts: Gell and Coombs classification, Ehrlich, Pasteur.
• Identify common autoimmune diseases: SLE, RA, MS, myasthenia gravis.
• Comprehend the effects of chemotherapy and immunosuppressive drugs on immune function.
• Recognize the causes and clinical implications of neutropenia and infection risk.
• Be familiar with HIV pathogenesis and its impact on immune cells.
• Know the main treatments for autoimmune diseases and hypersensitivity reactions.